TrademarkDir
ORPHACOL
LIVE

Serial Number

79144155

Owner

THERAVIA

Attorney

M. Scott Alprin

Filing Date

Jan 23, 2014

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ORPHACOL Trademark

Serial Number: 79144155 • Registration: 4701849

ORPHACOL is a trademark filed by THERAVIA on January 23, 2014. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

THERAVIA (5 trademarks)

16 RUE MONTROSIER
NEUILLY-SUR-SEINE 92200 , FR

Entity Type: 11

LABORATOIRES C.T.R.S. (6 trademarks)

68 rue de l'Est

Entity Type: 99

Trademark Details

Filing Date

January 23, 2014

Registration Date

March 17, 2015

Published for Opposition

December 30, 2014

Cancellation Date

March 6, 2026

Goods & Services

Pharmaceutical and veterinary products for treating deficits in primary bile acids synthesis and for preventing the need for liver transplantation for individuals of all ages; pills, capsules, tablets, powders, liquid, and drinkable solutions pertaining to healthy diet for use in treating oncological diseases; chemical preparations for medical or pharmaceutical use for treating deficits in primary bile acids synthesis and for preventing the need for liver transplantation of individuals of all ages

Filing History

CANCELLED SECTION 71
Mar 6, 2026 C71T
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Mar 17, 2024 REM4
INTERNATIONAL REGISTRATION RENEWED
Feb 15, 2024 RNWL
CHANGE OF NAME/ADDRESS REC'D FROM IB
Feb 12, 2024 ADCH
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Sep 1, 2022 NA71
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 1, 2022 APRE
REGISTERED-SEC.71 ACCEPTED
Sep 1, 2022 71AG
POST REGISTRATION ACTION MAILED - SEC.71
Aug 5, 2022 PR71
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 27, 2022 APRE
TEAS SECTION 71 RECEIVED
Sep 17, 2021 ES71
NEW REPRESENTATIVE AT IB RECEIVED
May 7, 2020 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 17, 2020 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Nov 15, 2019 NREP
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Oct 3, 2017 CORR
CORRECTION TRANSACTION RECEIVED FROM IB
Sep 29, 2017 CRCV
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 28, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 23, 2015 FICS
FINAL DISPOSITION PROCESSED
Jul 23, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 17, 2015 FICR
NEW REPRESENTATIVE AT IB RECEIVED
Jun 6, 2015 NREP
REGISTERED-PRINCIPAL REGISTER
Mar 17, 2015 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 30, 2014 NPUB
PUBLISHED FOR OPPOSITION
Dec 30, 2014 PUBO
NOTIFICATION PROCESSED BY IB
Dec 27, 2014 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 10, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 10, 2014 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 10, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 22, 2014 PREV
ASSIGNED TO LIE
Nov 22, 2014 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 4, 2014 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 4, 2014 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 4, 2014 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 4, 2014 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 4, 2014 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 1, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 31, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 31, 2014 TROA
REFUSAL PROCESSED BY IB
May 16, 2014 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 1, 2014 RFCS
REFUSAL PROCESSED BY MPU
May 1, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 1, 2014 RFCR
NON-FINAL ACTION WRITTEN
Apr 30, 2014 CNRT
ASSIGNED TO EXAMINER
Apr 29, 2014 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 25, 2014 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 21, 2014 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 20, 2014 REPR

Related Trademarks

More from this Owner

ADREPAN

ADREPAN

ADREPAN

ADREPAN

ADREPAN

ADREPAN

CT RS CELL THERAPIES RESEARCH & SERVICES logo

CT RS CELL THERAPIES RESEARCH & SERVICES

CT RS CELL THERAPIES RESEARCH & SERVICES logo

CT RS CELL THERAPIES RESEARCH & SERVICES

CT RS CELL THERAPIES RESEARCH & SERVICES logo

CT RS CELL THERAPIES RESEARCH & SERVICES